HALO
Halozyme Therapeutics, Inc. (HALO) Investor Questions
Review Halozyme Therapeutics, Inc. (HALO) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Halozyme Therapeutics, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 85
- Annual revenue
- $1.40B
- Annual net income
- $316.89M
- Annual free cash flow
- $644.59M
Halozyme Therapeutics, Inc. (HALO) Investor Questions research
Halozyme Therapeutics, Inc. trades under the ticker HALO. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review HALO through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.